Sanofi MS drug nears green light after pass-the-parcel marathon
By Ben Hirschler LONDON (Reuters) - One of the world's longest running drug development sagas may draw to a close this month as Fren...
Read More »Health News
Subscribe to the Health News feed.-
-
Kids' repeat concussions may mean longer recovery
By Genevra Pittman NEW YORK (Reuters Health) - Young people may take longer to recover after their second or third concussion, a new...
Read More » -
Dynavax's hepatitis B vaccine delayed as FDA seeks more data
(Reuters) - Dynavax Technologies Corp said the U.S. Food and Drug Administration asked for additional safety data on its experimenta...
Read More » -
FDA rejects Aveo kidney cancer drug, asks for additional trial
(Reuters) - Aveo Oncology said the Food and Drug Administration denied approval for its experimental kidney cancer drug citing incon...
Read More » -
AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion
By Ben Hirschler LONDON (Reuters) - AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billio...
Read More » -
Plant-based diets take root in U.S. among athletes, exercisers
By Dorene Internicola NEW YORK (Reuters) - For Brendan Brazier it all started with a smoothie. The former Ironman triathlete and ult...
Read More » -
Roche drug gets EU nod to treat arthritis in children
ZURICH (Reuters) - Swiss pharmaceuticals company Roche Holding AG said on Monday the European Medicines Agency has approved its rheu...
Read More » -
FDA approves four-strain Sanofi influenza vaccine
By Ransdell Pierson (Reuters) - French drugmaker Sanofi SA said the U.S. Food and Drug Administration had approved its four-strain i...
Read More » -
Elan says gets rival approaches, holds out for $15.50 per share cash
By Sophie Sassard LONDON (Reuters) - Ireland's Elan has attracted the interest of a number of mid-sized drug companies and a cash of...
Read More » -
FDA grants priority review status to Gilead's hepatitis C drug
(Reuters) - Biotechnology company Gilead Sciences Inc said the U.S. Food and Drug Administration (FDA) granted priority review to it...
Read More »